Synovial Fluid Extraction and Analysis Device

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current extraction and analysis systems for synovial fluid face challenges such as contamination, fluid loss, and the inability to provide real-time reliable diagnosis of periprosthetic joint infections, particularly during surgical interventions.

Innovation Solution

A device for real-time analysis of synovial fluid that includes an extraction line with a needle, syringe, and an analysis unit connected via a fluid-dynamic duct, featuring three-way valves, air filtering means, and receptacles with reagents like leukocyte esterase, CRP, and glucose, allowing for sterile collection and immediate infection assessment.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If synovial fluid is transferred into vacutainers or tubes for later analysis, then the fluid can be analyzed in a laboratory setting, but contamination and loss of fluid occur

Engineering Contradiction:
Improvediagnosis reliabilityVSAvoidcontamination
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent combines the fluid collection and analysis functions into a single integrated system. The extraction syringe connects directly to the analysis device through a fluid-dynamic connection, eliminating the intermediate transfer step to vacutainers. This merging of collection and analysis functions prevents contamination while enabling real-time diagnosis.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent introduces a sterile connection system as an intermediary between the extraction syringe and analysis device. This includes sterile adapters and fluid-dynamic connections that maintain sterility while enabling direct fluid transfer, thus preventing external contamination during the transition from collection to analysis.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If synovial fluid is transferred into vacutainers or tubes for later analysis, then the fluid can be analyzed in a laboratory setting, but loss of fluid occurs

Engineering Contradiction:
Improvediagnosis reliabilityVSAvoidfluid loss
Core Design Contradiction:
ReliabilityVSLoss of substance

Solution Approach 1:

The patent combines the fluid collection and analysis functions into a single integrated system. The extraction syringe connects directly to the analysis device through a fluid-dynamic connection, eliminating the intermediate transfer step to vacutainers. This merging of collection and analysis functions prevents contamination while enabling real-time diagnosis.

Inventive Principle:
Principle #5Merging (Combining)

3Loss of time

If traditional extraction and analysis systems are used, then fluid can be collected for later analysis, but real-time diagnosis is not possible

Engineering Contradiction:
Improvediagnosis timeVSAvoiddiagnosis reliability
Core Design Contradiction:
Loss of timeVSReliability

Solution Approach 1:

The patent prepares the analysis reagents and device in advance, connected and ready for immediate use. The extraction syringe is pre-assembled with sterile components, and the analysis device is pre-loaded with appropriate reagents. This preliminary preparation enables immediate analysis upon fluid extraction, achieving real-time diagnosis without compromising reliability.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent establishes a continuous workflow from fluid extraction through analysis. The fluid-dynamic connection allows uninterrupted flow of synovial fluid from the extraction syringe directly to the analysis device, eliminating pauses and transfer steps. This continuous action enables real-time diagnosis while maintaining sample integrity and diagnostic reliability.

Inventive Principle:
Principle #20Continuity of useful action

4Object-affected harmful factors

If sterile collection is performed in vacutainers for later laboratory analysis, then contamination can be avoided, but real-time analysis cannot be performed

Engineering Contradiction:
Improveexternal contaminationVSAvoidanalysis delay
Core Design Contradiction:
Object-affected harmful factorsVSLoss of time

Solution Approach 1:

The patent combines the fluid collection and analysis functions into a single integrated system. The extraction syringe connects directly to the analysis device through a fluid-dynamic connection, eliminating the intermediate transfer step to vacutainers. This merging of collection and analysis functions prevents contamination while enabling real-time diagnosis.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent establishes a continuous workflow from fluid extraction through analysis. The fluid-dynamic connection allows uninterrupted flow of synovial fluid from the extraction syringe directly to the analysis device, eliminating pauses and transfer steps. This continuous action enables real-time diagnosis while maintaining sample integrity and diagnostic reliability.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables immediate and reliable diagnosis of infection by detecting leukocyte esterase, CRP, and glucose levels in synovial fluid, reducing contamination and fluid loss, and allowing for both real-time analysis and subsequent laboratory testing without external contamination.

Implementation Method 1

The esterases are enzymes belonging to the class of hydrolases, which catalyze the hydrolysis reaction of the ester bond. In particular, the leukocyte esterase has the function to degrade proteins that act as a support to the connective tissue matrix.

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 2

The leukocyte esterase, also known as neutrophil elastase, or granulocyte elastase, is an enzyme synthesized by white blood cells, particularly by activated neutrophils, often found within infected body fluids.

Methodology Applied
Scientific EffectEnzyme catalysis: Enzyme

Implementation Method 3

said extraction duct (21) comprising a first three-way valve (23), having a first port (231), connected to said needle (22), a second port (232), connected to said inlet/outlet mouth (241) of said extraction syringe (24), and a third port (233), connectable to said analysis device (3), each of said ports being selectively opened or closed independently of the other

Methodology Applied
Scientific EffectFluid flow control: Valve

Data Source

PatentEP3344150B1Extraction and analysis device, in particular for synovial fluid
Publication Date: 2020.04.08 EON MEDICA SRL
  • EP3344150B1 patent drawingFigure 1~2
  • EP3344150B1 patent drawingFigure 3

AI summary

The present invention concerns a device for extraction and analysis (1) of anatomical tissues, such as synovial liquid and the like, comprising an extraction line (2, 21, 211, 212) of said tissue to be analyzed, having a needle (22), for the withdrawal of said tissue to be analyzed, an extraction duct (21, 211, 212), an extraction syringe (24), having an inlet/outlet mouth connected fluid-dynamically to said needle (22) by means of said extraction duct (21, 211, 212), and an analysis device (3), fluid-dynamically connected to said inlet/outlet mouth of said extraction syringe (24) by means of said extraction duct (21, 211, 212), said analysis device (32) having one or more receptacles (321, 322, 323), in each of which a respective reagent is arranged, and reading means (33), for detecting possible alterations of said reagents.